Socrus Bio Sciences Ltd - Stock Valuation and Financial Performance

BSE: 524719 | NSE: | Hospital & Healthcare Services | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Socrus Bio Sciences

M-Cap below 100cr DeciZen not available

Socrus Bio Sciences stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
1.5 Cr.
52-wk low:
0.5
52-wk high:
0.5

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Socrus Bio Sciences:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'11Mar'12Mar'13TTM
ROCE % 0.6%-0.5%0.4%-3%0.3%0.7%0.3%19.5%13.5%-137.4%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 36.811.432.811.79.55.35.722.130.219.91
Sales YoY Gr.--69.1%188.3%-64.5%-18.4%-44.1%7.1%287.4%36.6%-34.1%-
Adj EPS 0.1-0.10-1.2-0.10.20.11.41.6-9-0
YoY Gr.--216.7%NA-11900%NANA-72.2%2780%11.1%-662.5%-
BVPS (₹) 109.89.88.77.98.18.111.112.70.40.4
Adj Net
Profit
0.1-0.10-1.7-0.10.30.14.65.1-28.80
Cash Flow from Ops. -1.6-7.9-5.1-51.4-2.2-4.9703.3-0.1-3.3-
Debt/CF from Ops. -0.1-1-2.7-1.3-30.1-14.20000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -6.6%15.9%51.7%-34.1%
Adj EPS -274.5%NA-664.6%-662.5%
BVPS-30%-45%-63.3%-96.9%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'11Mar'12Mar'13TTM
Return on
Equity %
0.6-0.70.1-12.8-1.12.20.619.513.5-137.4-9.5
Op. Profit
Mgn %
0.4-1.4-2.7-24.7-1-6.2-2.218.921.4-100.3-9.8
Net Profit
Mgn %
0.2-0.90.1-14.8-1.44.91.220.917-144.8-10.9
Debt to
Equity
00.615.25.75.90000-
Working Cap
Days
1205032671,6302,8915,2992,8611691701740
Cash Conv.
Cycle
76282922312484694391181221210

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Socrus Bio Sciences Ltd.

Standalone Consolidated
TTM EPS (₹) -0 -
TTM Sales (₹ Cr.) 1.2 -
BVPS (₹.) 0.4 -
Reserves (₹ Cr.) -31 -
P/BV 1.10 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 0.48 / 0.49
All Time Low / High (₹) 0.48 / 24.00
Market Cap (₹ Cr.) 1.5
Equity (₹ Cr.) 32
Face Value (₹) 10
Industry PE 83.6

Management X-Ray of Socrus Bio Sciences:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Socrus Bio Sciences

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'11Mar'12Mar'13
Sales36.8411.3932.8411.669.515.325.7022.0830.1619.89
Operating Expenses 36.7111.5533.7314.549.605.695.8217.9123.6954.93
Manufacturing Costs0.0100.490000000.01
Material Costs36.4611.1932.8214.109.405.505.6817.7523.5133.27
Employee Cost 0.060.150.160.170.060.100.110.100.110.10
Other Costs 0.190.200.250.270.140.080.040.050.0721.55
Operating Profit 0.13-0.16-0.88-2.88-0.09-0.36-0.134.176.47-35.04
Operating Profit Margin (%) 0.4%-1.4%-2.7%-24.7%-0.9%-6.8%-2.2%18.9%21.4%-176.0%
Other Income 0.070.201.110.810.640.850.360.140.040
Interest 00.010.130.170.540.400.09000
Depreciation 0.090.080.060.060.060.060.060.060.054.32
Exceptional Items 0-0.2500-1.3200000
Profit Before Tax 0.11-0.300.03-2.31-1.380.020.084.246.46-39.36
Tax 0.02-0.020.01-0.58-0.32-0.220.01-0.381.330
Profit After Tax 0.09-0.270.01-1.73-1.060.240.074.625.12-39.36
PAT Margin (%) 0.2%-2.4%0.0%-14.8%-11.2%4.4%1.2%20.9%17.0%-197.0%
Adjusted EPS (₹)0.1-0.20.0-1.2-0.70.20.11.41.6-12.3
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'11Mar'12Mar'13

Equity and Liabilities

Shareholders Fund 14.6714.4014.4112.6811.6211.8611.8835.5240.641.27
Share Capital 14.6514.6514.6514.6514.6514.6514.65323232
Reserves 0.02-0.25-0.24-1.97-3.03-2.80-2.783.518.63-30.73
Minority Interest0000000000
Debt0.228.0114.0365.3466.1570.070000
Long Term Debt0.228.0114.0365.3466.1570.070000
Short Term Debt0000000000
Trade Payables0.290.153.701.830.190.010.010.040.060.96
Others Liabilities -0.19-0.21-0.15-0.77-1.03-1.46-1.41-1.96-0.63-0.63
Total Liabilities 1522.3531.9979.0876.9480.4710.4733.5940.071.61

Fixed Assets

Gross Block2.081.611.611.621.621.621.6223.7623.764.32
Accumulated Depreciation0.720.580.640.710.770.840.901.041.094.32
Net Fixed Assets1.361.040.970.910.840.780.7122.7322.680
CWIP 0000000000
Investments 1.501.492.282.280.7600000
Inventories6.188.157.426.516.566.236.232.116.060.91
Trade Receivables3.040.584.301.320.560.550.725.346.820
Cash Equivalents 0.290.170.280.200.340.120.020.120.050.01
Others Assets2.6310.9316.7467.8767.8872.802.793.314.450.70
Total Assets 1522.3531.9979.0876.9480.4710.4733.5940.071.61

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'11Mar'12Mar'13
Cash Flow From Operating Activity -1.63-7.94-5.12-51.39-2.20-4.9369.983.30-0.06-3.30
PBT 0.11-0.050.03-2.31-1.38-0.010.084.246.46-39.36
Adjustment 0.150.150.060.060.060.060.060.060.0519.42
Changes in Working Capital -1.88-8.05-5.21-49.12-0.88-4.9869.84-1.01-6.5716.64
Tax Paid 000-0.02000000
Cash Flow From Investing Activity 1.390.03-0.7901.520.78-70.07-22.1803.26
Capex 000000-70.07-4.3203.26
Net Investments 1.360.02-0.7901.520.760000
Others 0.040.020000.020-17.8600
Cash Flow From Financing Activity 0.217.796.0251.310.823.92018.9100
Net Proceeds from Shares 000000017.3500
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others 0.217.796.0251.310.823.9201.5600
Net Cash Flow -0.02-0.120.11-0.080.15-0.23-0.090.03-0.06-0.04
PARTICULARSMar'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'11Mar'12Mar'13
Ratios
ROE (%)0.61-1.890.1-12.77-8.7420.619.5113.45-187.84
ROCE (%)0.76-1.520.62-4.02-1.080.530.3617.9216.96-187.83
Asset Turnover Ratio2.280.611.210.210.120.070.1310.820.95
PAT to CFO Conversion(x)-18.11N/A-512N/AN/A-20.54999.710.71-0.01N/A
Working Capital Days
Receivable Days4358278836384150740
Inventory Days4823087218251438399694964
Payable Days17721713970016

Socrus Bio Sciences Ltd Stock News

Socrus Bio Sciences Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Socrus Bio Sciences on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Socrus Bio Sciences stood at ₹1.54.
The latest P/E ratio of Socrus Bio Sciences as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Socrus Bio Sciences as of 01-Jan-1970 05:30 is 1.10.
The 52-week high of Socrus Bio Sciences is ₹0.49 and the 52-week low is ₹0.48.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Socrus Bio Sciences is ₹1.17 ( Cr.) .

About Socrus Bio Sciences Ltd

Socrus Bio Sciences is engaged in the agro biotech business in India. It offers natural remedies for various indications under the Agnihotri brand name.

The company’s products include piles clear, kabj rahat churan, madhushala amrut, pens stick, glucose, lal dant manjan, burn-nil, heal-up, BDK tablets, pimple clear gels, jatamansi tel, antiseptic lotion, kali mirch, budhivardhak tel, M.K.C.K goli, and P.J. capsules.

The company, was formerly known as Tanu Health Care, is based in Mumbai, India.

The registered office is located at 30, 16-A, PMGP Colony, Mahakali Cave Road, MIDC, Andheri (East), Mumbai - 400 093, Maharashtra.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.